About Us
Company Profile
Company Name: Vitalive Inc.
Head Office 5-36-4 Shiba, Minato-ku, Tokyo 108-0014
Fudanotsuji Square 9th floor
Established July 29, 2024
Capital: 66.39 million yen (including capital reserve)
Makoto Inoue, Representative Director
Management Policy
Management Policy
1. People-oriented management
1. We prioritize protecting the safety and rights of clinical trial participants.
2. Improve the work efficiency and job satisfaction of medical professionals
3. We support the growth and happiness of our employees
2. Quality-oriented technological development
1. We provide a system that is fully compliant with GxP requirements
2. We use the latest technology to solve problems in the medical field.
3. Pursue continuous quality improvement
3. Pursuit of reliability
4. Co-creation of value
5. Sustainable growth
1. We maintain a strict risk management system.
2. We will establish a highly transparent business process.
3. We will ensure thorough compliance
1. We will work closely with medical institutions.
2. We listen sincerely to what our patients have to say
3. We value cooperative relationships with those involved in clinical trials.
1. We promote continuous innovation
2. We support employees in improving their expertise
3. Maintain a sound financial base
Management Guidelines
Management Guidelines
CEO's Message
Message from the CEO
[Brief biography]
Since 2003, he has served as an executive officer and director at the CMIC Group.
Since 2019, he has served as an officer and director at Buzzreach.
July 2024: Vitalive Inc. was founded
We will work to resolve various issues based on our knowledge, experience, and personal connections gained over 20 years in the clinical trial industry.
As our company logo indicates, the business we are involved in aims to be that blue bird that "brings happiness to everyone involved in clinical trials." We hope that not only will we create unprecedented services, but that these will also be useful to all those involved in clinical trials.
